Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ERNAthis companyErnexa Therapeutics Inc.	$1.93	-0.54×	3.15×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-586.6%	-316.6%	-93.2%	0.2×	0.1×	-345.15×	1.01×	0.0%	2	-64.61	2	B-
AEMDAethlon Medical, Inc.	$5.41	-1.03×	1.51×	0×	-0.39×	21.8%	0.0%	0.0%	0.0%	-146.4%	-139.6%	-95.0%	0.07×	0.69×	-507.49×	3.85×	0.0%	1	-40.86	3	B-
AEONAEON Biopharma, Inc.	$0.18	-0.28×	-0.2×	0×	-2.69×	-1320.4%	0.0%	0.0%	0.0%	71.3%	1180.0%	-158.6%	-0.65×	-2.02×	0×	0.49×	0.0%	2	-129.27	2	C
DWTXDogwood Therapeutics, Inc.	$1.17	-0.96×	0.46×	0×	-0.82×	-43.2%	0.0%	0.0%	0.0%	-45.7%	-32.1%	-45.7%	0×	0.19×	0×	2.76×	0.0%	1	-1.2	3	B
MBRXMoleculin Biotech, Inc.	$8.65	-0.12×	0.26×	0×	0.14×	983.9%	0.0%	0.0%	0.0%	-223.6%	-162.9%	-579.8%	0.02×	0.25×	0×	1.41×	0.0%	1	-19.26	3	B-
MPLTMapLight Therapeutics, Inc.	$7.37	-4.8×	1.69×	0×	-4.56×	-86.3%	0.0%	0.0%	0.0%	-35.2%	-36.4%	-17.9%	0.01×	0.25×	0×	20.01×	0.0%	2	5.7	2	C
Peer median	—	-0.96×	0.46×	0×	-0.82×	-43.2%	0.0%	0.0%	0.0%	-45.7%	-36.4%	-95.0%	0.01×	0.25×	0×	2.76×	0.0%	1	-19.26	3	—